Table 1.
Patient demographics in this study.
| Nonfunctioning tumor (N = 969) | GH-secreting tumor (N = 317) | P | |
| Age, yr | 46.68 ± 13.87 | 44.06 ± 12.09 | .001 |
| Sex (male/female) | 362/607 | 147/170 | .004 |
| Height, cm | 164.45 ± 8.34 | 168.27 ± 10.11 | <.001 |
| Weight, kg | 65.77 ± 12.85 | 71.62 ± 14.15 | <.001 |
| BMI | 24.23 ± 3.82 | 25.14 ± 3.48 | <.001 |
| ASA (1/2/3/4) | 284/558/123/4 | 0/261/55/1 | <.001 |
| Hypertension | 198 (20.4%) | 102 (32.2%) | <.001 |
| Diabetes mellitus | 79 (8.2%) | 74 (23.3%) | <.001 |
| Coronary artery disease | 23 (2.4%) | 4 (1.3%) | .231 |
| Duration of surgery, min | 181.19 ± 78.34 | 206.10 ± 94.64 | .002 |
| Duration of anesthesia, min | 273.80 ± 89.41 | 291.95 ± 100.76 | .002 |
| Tumor size (> 1 cm) | 871 (89.9%) | 275 (86.8%) | .120 |
| Sinus invasion | 372 (38.3%) | 128 (40.4%) | .528 |
| Bleeding, mL | 238.65 ± 267.69 | 265.87 ± 249.16 | .110 |